XML 56 R46.htm IDEA: XBRL DOCUMENT v3.24.1.u1
STOCK BASED COMPENSATION (Tables)
3 Months Ended
Mar. 31, 2024
STOCK BASED COMPENSATION  
Schedule of option activity

The option activity of the Plans for the three months ended March 31, 2024, is as follows (shares in thousands):

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

    

​

    

Weighted-Average 

 

​

​

​

​

​

​

Weighted-Average 

​

Remaining 

 

Aggregate

​

​

Number of 

​

Exercise Price 

​

Contractual Term 

 

Intrinsic Value

​

    

Shares

    

per Share

    

(in years)

 

(in thousands)

Outstanding at January 1, 2024

​

6,164

​

$

1.83

 

4.97

​

$

140

Forfeited/expired

 

(177)

​

$

1.40

​

​

​

​

—

Outstanding at March 31, 2024

 

5,987

​

$

1.83

​

4.69

​

​

210

Options vested at March 31, 2024

 

5,804

​

$

1.85

​

4.64

​

​

210

Options vested or expected to vest at March 31, 2024

 

5,986

​

$

1.83

​

4.69

​

​

210

Schedule of RSU activity under the Plan

The activity for stock subject to vesting as of March 31, 2024, is as follows (shares in thousands):

​

​

​

​

​

​

​

​

Shares Subject 

    

Weighted-Average

​

    

to Vesting

    

Grant Date Fair Value

Balance of unvested shares as of January 1, 2024

​

6

 

$ 8.78

Vested

 

(6)

​

$ 8.78

Balance of unvested shares as of March 31, 2024

 

—

 

$ 8.78

Schedule of RSU activity

RSU activity under the 2020 Plan for the three months ended March 31, 2024, is as follows (shares in thousands):

​

​

​

​

​

​

​

​

Shares Subject 

    

Weighted-Average

​

    

to Vesting

    

Grant Date Fair Value

Balance of unvested shares as of January 1, 2024

​

23,055

​

$ 2.84

Granted

​

9,008

​

$ 0.76

Vested

​

(4,964)

​

$ 1.76

Cancelled/Forfeited

​

(1,522)

​

$ 3.51

Balance of unvested shares as of March 31, 2024

​

25,577

​

$ 2.28

Schedule of stock-based compensation expense

Total stock-based compensation expense related to all of the Company’s stock-based awards granted is reported in the condensed consolidated statements of operations as follows (in thousands):

​

​

​

​

​

​

​

​

​

Three Months Ended March 31, 

​

​

2024

    

2023

Research and development

​

$

3,503

​

$

4,277

General and administrative expense

​

 

3,178

​

 

3,968

Sales and marketing expense

​

 

589

​

 

388

Cost of sales

​

 

568

​

 

680

Total stock-based compensation expense

​

$

7,838

​

$

9,313